Omega Diagnostics Group (ODX)

 

ODX Share PerformanceMore

52 week high26.62 25/05/17
52 week low15.78 20/12/16
52 week change 2.36 (14.29%)
4 week volume1,398,799 22/10/17

Media for (ODX)

Presenter: Kieron Harbinson, Group Finance Director
06/07/2015
Presenter: Kieron Harbinson, Group Finance Director
14/04/2015

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Change of Registered Office

RNS Number: 0827V Omega Diagnostics Group PLC 01 November 2017 Omega Diagnostics Group PLC ("Omega" or "the Company") Change of Registered Office Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that with immediate effect, the registered office of the Company has been cha...

Omega Diagnostics expects 4% revenue rise

Omega Diagnostics Group said it expects first-half revenue to increase by 4% to 7.11m on-year. In constant currency terms, ...

Trading Update and Notice of Interim Results

RNS Number: 2507U Omega Diagnostics Group PLC 23 October 2017 Omega Diagnostics Group PLC ("Omega" or "the Company") Trading Update and Notice of Interim Results Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces the following trading update for the six months to 30 Septembe...

PDMR Participation in SAYE Scheme

RNS Number: 9229T Omega Diagnostics Group PLC 18 October 2017 Omega Diagnostics Group PLC ("Omega" or the "Company") PDMR participation in SAYE scheme Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that certain PDMRs of the Company have been granted sharesave option...

Omega Diagnostics signs US supply agreement

Omega Diagnostics has signed a supply agreement with a US-based company offering laboratory testing services, specialisi...

US Supply Agreement

RNS Number: 6226T Omega Diagnostics Group PLC 16 October 2017 Omega Diagnostics Group PLC ("Omega" or the "Company") US Supply Agreement Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that it has signed a Supply Agreement with a US-based company offering laboratory tes...

Holding(s) in Company

RNS Number: 1262T Omega Diagnostics Group PLC 10 October 2017 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: OMEG...

Exercise of Options and Total Voting Rights

RNS Number: 8780P Omega Diagnostics Group PLC 05 September 2017 5 September 2017 Omega Diagnostics Group PLC ("Omega" or the "Company") Exercise of Options and Total Voting Rights Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that it has allotted 75,000 new ordinary shares...

Fundamental DataMore

P/E ratio26.964
EPS0.7
Dividend yield0 %

Latest discussion posts More

  • Final Results one month later in 2017

    Last year the financial results for the ye 30th. September were issued On the 21st. November 2016. The 2017 results will be issued nearly a month later. This suggests that ...
    31-Oct-2017
    mnbvvvvvvvvvvvcxz
  • where's the beef- Wendy? no.2

    Ok so rain in Germany meant fewer allergens triggering allergies. Hence consumption of manual tests is down. The Immuno Diagnostics tie up seems to be wading through ...
    23-Oct-2017
    mnbvvvvvvvvvvvcxz
  • Re: where's the beef- Wendy?

    Today is to show they are executing on one of the reasons for the funding round. Investors paid their money, ODX has started to deliver one item. Expect the others to follow ...
    16-Oct-2017
    Carefully Does It

Users' HoldingsMore

Users who hold Omega Diagnostics Group also hold..
LLOYDS GRP.34%
SAINSBURY(J)21%
ROYAL BANK SCOT21%
VODAFONE GRP.18%
CENTRICA18%

Codes & Symbols

ISINGB00B1VCP282
SymbolsODX, LSE:ODX, ODX.L, ODX:LN, LON:ODX, XLON:ODX

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account